|
27 Jan 2011 |
The University of Massachusetts and Lundbeck Enter Research Collaboration to Explore Potential Targeted Therapy for Huntington’s Disease
|
|
25 Jan 2011 |
Alnylam Receives Positive Opinion for Orphan Drug Designation from European Medicines Agency for ALN-TTR01, an RNAi Therapeutic for the Treatment of Transthyretin-Mediated Amyloidosis
|
|
20 Jan 2011 |
Overview of Aastrom RESTORE-CLI and IMPACT-DCM Clinical Results Presented Today at the Conference on Cell Therapy for Cardiovascular Disease
|
|
19 Jan 2011 |
Geron Initiates Phase 2 Clinical Trial of Imetelstat in Essential Thrombocythemia
|
|
19 Jan 2011 |
GSK and Prosensa Announce Start of Phase III Study of Investigational Duchenne Muscular Dystrophy Medication
|
|
18 Jan 2011 |
EHSI Forms Joint Venture to Develop Stem-Cell Treatment for Liver Disease
|
|
18 Jan 2011 |
Mirna Therapeutics and Collaborators Publish New Data on miR-34 and its Role in Cancer Stem Cells
|
|
18 Jan 2011 |
Oncolytics Biotech Inc. Announces 2-Arm, Randomized Phase II Pancreatic Cancer Study
|
|
18 Jan 2011 |
Pluristem on Track to Proceed to a Phase II/III Clinical Trial in Critical Limb Ischemia (CLI) Under a Joint FDA-EMA Protocol, and a Phase II Clinical Trial in Intermittent Claudication (IC)
|
